⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL697887 | 1.00 | — | — | |
| SCHEMBL9530406 | 1.00 | — | — | |
| SCHEMBL28147592 | 0.97 | ADH1B (0.46) | — | |
| Hydrochloric Acid SCHEMBL28009514 | 0.97 | — | — | |
| SCHEMBL4229324 | 0.97 | — | — | |
| SCHEMBL4229332 | 0.97 | — | — | |
| Benzene SCHEMBL28325661 | 0.95 | ADH1B (0.43) | — | |
| Alanine SCHEMBL23044934 | 0.91 | ADH1B (0.40) | — | |
| Nitrous Acid SCHEMBL8342017 | 0.91 | ADH1B (0.40) | — | |
| Nitrous Acid SCHEMBL8342021 | 0.91 | ADH1B (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119569672-A | Preparation method of amino acid derivative | 四川鸿日医药科技有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-110423226-B | Preparation method of 4-methyl-5-alkoxy oxazole | 山东新和成精化科技有限公司 | 2021-01-05 | — | — | CN | claimed |
| EP-1713806-B1 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | IRM LLC (BM) | 2013-05-08 | — | — | EP | claimed |
| US-7968557-B2 | Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs | NOVARTIS AG (CH) | 2011-06-28 | — | — | US | claimed |
| WO-2008126030-A2 | COMPOSITIONS FOR REGULATION OF HAIR GROWTH | THE PROCTER & GAMBLE COMPANY (US) | 2008-10-23 | — | — | WO | claimed |
| US-20080254055-A1 | Compositions for Regulation of Hair Growth | PROCTER & GAMBLE COMPANY, THE | 2008-10-16 | — | — | US | claimed |
| US-20070225306-A1 | Compounds and Compositions as Protein Kinase Inhibitors | IRM LLC (BM) | 2007-09-27 | — | — | US | claimed |
| EP-1713806-A1 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | IRM, LLC (BM) | 2006-10-25 | — | — | EP | claimed |
| WO-2005107760-A1 | COMPOUNDS AND COMPOSITIONS AS INDUCERS OF KERATINOCYTE DIFFERENTIATION | IRM LLC (BM) | 2005-11-17 | — | — | WO | claimed |
| WO-2005080393-A1 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | IRM LLC (BM) | 2005-09-01 | — | — | WO | claimed |
| WO-2000020400-A1 | NOVEL COMPOUNDS AND COMPOSITIONS FOR TREATING HEPATITIS C INFECTIONS | AXYS PHARMACEUTICALS, INC. (US) | 2000-04-13 | — | — | WO | claimed |
| US-4801580-A | Peptide, process for preparation thereof and use thereof | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1989-01-31 | — | — | US | claimed |
| US-4749691-A | Peptide, process for preparation thereof and use thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-06-07 | — | — | US | claimed |
| US-4725582-A | IMMUNE RESPONSE ENHANCERS | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1988-02-16 | — | — | US | claimed |
| EP-0025842-B1 | PEPTIDES, PROCESS FOR THEIR PREPARATION, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR INTERMEDIATES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-06-03 | — | — | EP | claimed |
| EP-0055846-B1 | NEW PEPTIDE, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING IT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-03-19 | — | — | EP | claimed |
| US-4574058-A | Antigen derivatives and processes for their preparation | CIBA-GEIGY CORPORATION (US) | 1986-03-04 | — | — | US | claimed |
| US-4493794-A | BACTERICIDE, FUNGICIDE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1985-01-15 | — | — | US | claimed |
| US-4446128-A | Antigen derivatives and processes for their preparation | CIBA-GEIGY CORPORATION (US) | 1984-05-01 | — | — | US | claimed |
| US-20250288559-A1 | PREP BINDING LIGANDS | POLKU THERAPEUTICS OY (FI) | 2025-09-18 | — | — | US | disclosed |
| CN-119569672-A | Preparation method of amino acid derivative | 四川鸿日医药科技有限公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119569672-A | Preparation method of amino acid derivative | 四川鸿日医药科技有限公司 | 2025-03-07 | — | — | CN | disclosed |
| EP-4514781-A1 | PREP BINDING LIGANDS | Polku Therapeutics OY (FI) | 2025-03-05 | — | — | EP | disclosed |
| CN-119451944-A | PREP binding ligands | 珀尔库治疗有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-112390888-B | Stable formulations containing anti-PCSK 9 antibodies | 美国安进公司 | 2025-02-11 | — | — | CN | disclosed |
| US-20240360105-A1 | PROCESS FOR POLYAMIDE SYNTHESIS | Design Therapeutics, Inc. | 2024-10-31 | — | — | US | disclosed |
| EP-4326709-A1 | METHODS OF SYNTHESIZING LIPSTATIN DERIVATIVES | Panafina, Inc. (US) | 2024-02-28 | — | — | EP | disclosed |
| EP-4326709-A1 | METHODS OF SYNTHESIZING LIPSTATIN DERIVATIVES | Panafina, Inc. (US) | 2024-02-28 | — | — | EP | disclosed |
| WO-2023209191-A1 | PREP BINDING LIGANDS | UNIVERSITY OF HELSINKI (FI) | 2023-11-02 | — | — | WO | disclosed |
| US-RE49594-E1 | Apelin receptor (APJ) agonists and uses thereof | RESEARCH TRIANGLE INSTITUTE (US) | 2023-08-01 | — | — | US | disclosed |
| CN-114644577-B | Environment-friendly preparation method of substituted isonitrile compound | 新发药业有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-111683720-B | Hair treatment composition | 联合利华知识产权控股有限公司 | 2023-04-25 | — | — | CN | disclosed |
| US-11535630-B2 | Apelin receptor (APJ) agonists and uses thereof | RESEARCH TRIANGLE INSTITUTE (US) | 2022-12-27 | — | — | US | disclosed |
| WO-2022226156-A1 | METHODS OF SYNTHESIZING LIPSTATIN DERIVATIVES | PANAFINA, INC. (US) | 2022-10-27 | — | — | WO | disclosed |
| CN-108473439-B | Pyrazolone derivatives as nitroxyl donors | 卡尔迪奥克斯尔制药公司 | 2022-03-15 | — | — | CN | disclosed |
| US-20220000814-A1 | METHODS FOR TREATMENT OF PRADER-WILLI SYNDROME | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) | 2022-01-06 | — | — | US | disclosed |
| US-11058652-B2 | Methods for treatment of Prader-Willi syndrome | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2021-07-13 | — | — | US | disclosed |
| EP-3490975-B1 | O-SUBSTITUTED HYDROXAMIC ACIDS | UNIV JOHNS HOPKINS (US) | 2021-05-05 | — | — | EP | disclosed |
| EP-3313831-B1 | N-SUBSTITUTED HYDROXAMIC ACIDS WITH CARBON-BASED LEAVING GROUPS AS EFFICIENT HNO DONORS AND USES THEREOF | UNIV JOHNS HOPKINS (US) | 2021-03-10 | — | — | EP | disclosed |
| WO-2021037022-A1 | METHOD FOR PREPARING 4-METHYL-5-ALKOXY OXAZOLE | 山东新和成精化科技有限公司 | 2021-03-04 | — | — | WO | disclosed |
| US-10913728-B2 | O-substituted hydroxamic acids | THE JOHNS HOPKINS UNIVERSITY (US) | 2021-02-09 | — | — | US | disclosed |
| EP-3432874-B1 | METHODS AND COMPOSITIONS FOR TREATMENT OF PRADER-WILLI SYNDROME | YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (IL) | 2021-01-13 | — | — | EP | disclosed |
| CN-110423226-B | Preparation method of 4-methyl-5-alkoxy oxazole | 山东新和成精化科技有限公司 | 2021-01-05 | — | — | CN | disclosed |
| CN-111683720-A | Hair treatment composition | 荷兰联合利华有限公司 | 2020-09-18 | — | — | CN | disclosed |
| US-10723704-B2 | Pyrazolone derivatives as nitroxyl donors | CARDIOXYL PHARMACEUTICALS, INC. (US) | 2020-07-28 | — | — | US | disclosed |
| CN-111225717-A | Method for hair volume reduction | 荷兰联合利华有限公司 | 2020-06-02 | — | — | CN | disclosed |
| CN-111163809-A | Transglutaminase conjugation methods and linkers | 保罗·谢勒学院 | 2020-05-15 | — | — | CN | disclosed |
| US-10583141-B2 | N-substituted hydroxamic acids with carbon-based leaving groups as efficient HNO donors and uses thereof | THE JOHNS HOPKINS UNIVERSITY (US) | 2020-03-10 | — | — | US | disclosed |
| EP-3490975-A1 | O-SUBSTITUTED HYDROXAMIC ACIDS | The Johns Hopkins University (US) | 2019-06-05 | — | — | EP | disclosed |
| US-20190161464-A1 | O-SUBSTITUTED HYDROXAMIC ACIDS | NATIONAL SCIENCE FOUNDATION | 2019-05-30 | — | — | US | disclosed |
| US-20190151264-A1 | METHODS FOR TREATMENT OF PRADER-WILLI SYNDROME | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2019-05-23 | — | — | US | disclosed |
| US-20180318308-A1 | PYRAZOLONE DERIVATIVES AS NITROXYL DONORS | CARDIOXYL PHARMACEUTICALS, INC. | 2018-11-08 | — | — | US | disclosed |
| EP-3365328-A1 | PYRAZOLONE DERIVATIVES AS NITROXYL DONORS | Cardioxyl Pharmaceuticals, Inc. (US) | 2018-08-29 | — | — | EP | disclosed |
| US-20180185367-A1 | N-SUBSTITUTED HYDROXAMIC ACIDS WITH CARBON-BASED LEAVING GROUPS AS EFFICIENT HNO DONORS AND USES THEREOF | NATIONAL SCIENCE FOUNDATION | 2018-07-05 | — | — | US | disclosed |
| EP-3313831-A1 | N-SUBSTITUTED HYDROXAMIC ACIDS WITH CARBON-BASED LEAVING GROUPS AS EFFICIENT HNO DONORS AND USES THEREOF | The Johns Hopkins University (US) | 2018-05-02 | — | — | EP | disclosed |
| CN-107850844-A | Photosensitive resin composition, method for producing cured relief pattern, and semiconductor device | 旭化成株式会社 | 2018-03-27 | — | — | CN | disclosed |
| WO-2018022899-A1 | O-SUBSTITUTED HYDROXAMIC ACIDS | THE JOHNS HOPKINS UNIVERSITY (US) | 2018-02-01 | — | — | WO | disclosed |
| EP-2763648-B1 | HAIR CARE COMPOSITIONS AND METHODS OF USE | PROCTER & GAMBLE (US) | 2017-11-29 | — | — | EP | disclosed |
| WO-2017179058-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF PRADER-WILLI SYNDROME | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD (IL) | 2017-10-19 | — | — | WO | disclosed |
| EP-2948452-B1 | 2,3-DIHYDROIMIDAZOL[1,2-C]PYRIMIDIN-5(1H)-ONE BASED LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) INHIBITORS | GLAXOSMITHKLINE IP DEV LTD (GB) | 2017-08-09 | — | — | EP | disclosed |
| US-9708330-B2 | 2,3-dihydroimidazol[1,2-C]pyrimidin-5(1-H)-one based ipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitors | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-07-18 | — | — | US | disclosed |
| US-9682938-B2 | Pyrazolone derivatives as nitroxyl donors | CARDIOXYL PHARMACEUTICALS, INC. (US) | 2017-06-20 | — | — | US | disclosed |
| US-9663488-B2 | Metalloenzyme inhibitor compounds | VIAMET PHARMACEUTICALS, INC. (US) | 2017-05-30 | — | — | US | disclosed |
| WO-2017070081-A1 | PYRAZOLONE DERIVATIVES AS NITROXYL DONORS | CARDIOXYL PHARMACEUTICALS, INC. (US) | 2017-04-27 | — | — | WO | disclosed |
| EP-3148972-A1 | PYRAZOLONE DERIVATIVES AS NITROXYL DONORS | Cardioxyl Pharmaceuticals Inc. (US) | 2017-04-05 | — | — | EP | disclosed |
| EP-2448548-B1 | METHOD FOR IMPROVING THE APPEARANCE OF HYPERPIGMENTED SPOT(S) USING AN EXTRACT OF LAMINARIA SACCHARINA | PROCTER & GAMBLE (US) | 2017-03-01 | — | — | EP | disclosed |
| US-20170007532-A1 | Cosmetic Products for Reducing Hair Appearance | THE PROCTER & GAMBLE COMPANY | 2017-01-12 | — | — | US | disclosed |
| WO-2016210392-A1 | N-SUBSTITUTED HYDROXAMIC ACIDS WITH CARBON-BASED LEAVING GROUPS AS EFFICIENT HNO DONORS AND USES THEREOF | THE JOHNS HOPKINS UNIVERSITY (US) | 2016-12-29 | — | — | WO | disclosed |
| US-9522884-B2 | Compositions and methods for the treatment of metabolic disorders | CELLIX BIO PRIVATE LIMITED (IN) | 2016-12-20 | — | — | US | disclosed |
| US-9522884-B2 | Compositions and methods for the treatment of metabolic disorders | CELLIX BIO PRIVATE LIMITED (IN) | 2016-12-20 | — | — | US | disclosed |
| US-20150361082-A1 | 2,3-DIHYDROIMIDAZOL[1,2-C]PYRIMIDIN-5(1-H)-ONE BASED IPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2015-12-17 | — | — | US | disclosed |
| US-20150353546-A1 | METALLOENZYME INHIBITOR COMPOUNDS | Viamet Pharmaceuticals (NC), Inc. | 2015-12-10 | — | — | US | disclosed |
| WO-2015183839-A1 | PYRAZOLONE DERIVATIVES AS NITROXYL DONORS | CARDIOXYL PHARMACEUTICALS, INC. (US) | 2015-12-03 | — | — | WO | disclosed |
| US-20150344437-A1 | PYRAZOLONE DERIVATIVES AS NITROXYL DONORS | THE JOHNS HOPKINS UNIVERSITY | 2015-12-03 | — | — | US | disclosed |
| EP-2948452-A1 | 2,3-DIHYDROIMIDAZOL[1,2-C]PYRIMIDIN-5(1H)-ONE BASED LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) INHIBITORS | GlaxoSmithKline Intellectual Property Development Limited (GB) | 2015-12-02 | — | — | EP | disclosed |
| EP-2948450-A1 | METALLOENZYME INHIBITOR COMPOUNDS | Viamet Pharmaceuticals, Inc. (US) | 2015-12-02 | — | — | EP | disclosed |
| US-9051325-B2 | Bicyclic [5,6] imidazo pyrimodone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2 | GLAXO GROUP LIMITED (GB) | 2015-06-09 | — | — | US | disclosed |
| US-20150141468-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS | MAHESH KANDULA (IN) | 2015-05-21 | — | — | US | disclosed |
| US-20150141468-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS | MAHESH KANDULA (IN) | 2015-05-21 | — | — | US | disclosed |
| EP-2854755-A2 | COSMETIC PRODUCTS FOR REDUCING HAIR APPEARANCE | The Procter & Gamble Company (US) | 2015-04-08 | — | — | EP | disclosed |
| US-8940665-B2 | Oil release with amino acid-based compounds having a long chain N-acyl group | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-01-27 | — | — | US | disclosed |
| US-8940664-B2 | Oil release with polyethylene oxide segment-containing N-lauroyl amino acid-based compounds | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-01-27 | — | — | US | disclosed |
| US-8912185-B2 | Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents | Obschestvo S Ogranichennoi Otvetstvennostyu “Pharmenterprises” (RU) | 2014-12-16 | — | — | US | disclosed |
| US-20140213599-A1 | COMPOUNDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2014-07-31 | — | — | US | disclosed |
| WO-2014117090-A1 | METALLOENZYME INHIBITOR COMPOUNDS | VIAMET PHARMACEUTICALS, INC. (US) | 2014-07-31 | — | — | WO | disclosed |
| WO-2014114694-A1 | 2,3-DIHYDROIMIDAZOL[1,2-C]PYRIMIDIN-5(1H)-ONE BASED LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) INHIBITORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2014-07-31 | — | — | WO | disclosed |
| CN-103880766-A | Simple and convenient preparation method of 4-methyl-5-alkoxy oxazole | XINFA PHARMACEUTICAL CO LTD | 2014-06-25 | — | — | CN | disclosed |
| CN-103869614-A | PHOTOSENSITIVE RESIN COMPOSITION,PHOTOSENSITIVE ELEMENT, PHOTOSENITIVE ELEMENT COIL AND PHOTORESISTANCE PATTERN FORMING METHOD | HITACHI CHEMICAL CO LTD | 2014-06-18 | — | — | CN | disclosed |
| EP-2423211-B1 | PROCESSES FOR PRODUCING (1S,6S)- OR (1R,6R)-CIS-2,8-DIAZABICYCLO[4.3.0]NONANE AND INTERMEDIATE THEREOF | KANEKA CORP (JP) | 2014-04-16 | — | — | EP | disclosed |
| WO-2013181010-A2 | COSMETIC PRODUCTS FOR REDUCING HAIR APPEARANCE | THE PROCTER & GAMBLE COMPANY (US) | 2013-12-05 | — | — | WO | disclosed |
| US-20130323191-A1 | COSMETIC PRODUCTS FOR REDUCING HAIR APPEARANCE | THE PROCTER & GAMBLE COMPANY (US) | 2013-12-05 | — | — | US | disclosed |
| WO-2013167991-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS | KANDULA MAHESH (IN) | 2013-11-14 | — | — | WO | disclosed |
| EP-1713806-B1 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | IRM LLC (BM) | 2013-05-08 | — | — | EP | disclosed |
| US-20130095562-A1 | OIL RELEASE WITH AMINO ACID-BASED COMPOUNDS HAVING A LONG CHAIN N-ACYL GROUP | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-04-18 | — | — | US | disclosed |
| US-20130079259-A1 | OIL RELEASE WITH POLYETHYLENE OXIDE SEGMENT-CONTAINING N-LAUROYL AMINO ACID-BASED COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-03-28 | — | — | US | disclosed |
| CN-102520580-A | Method for forming photoresist pattern | HITACHI CHEMICAL CO LTD | 2012-06-27 | — | — | CN | disclosed |
| EP-1311269-B1 | METHOD OF USING DIKETOPIPERAZINES AND COMPOSITION CONTAINING THEM | DMI BIOSCIENCES INC (US) | 2012-02-29 | — | — | EP | disclosed |
| EP-2423211-A1 | PROCESSES FOR PRODUCING (1S,6S)- OR (1R,6R)-CIS-2,8-DIAZABICYCLO[4.3.0]NONANE AND INTERMEDIATE THEREOF | Kaneka Corporation (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-7968557-B2 | Diseases with abnormal activation of the Abl, BCR-Abl, Bmx, CSK, TrkB, FGFR3, Fes, Lck, B-RAF, C-RAF, MKK6, alpha and beta SAPK2 kinases; antiproliferative; pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-phenylcarbamoyl-phenyl]-amides and pyrrolo[3,2-c]pyridine analogs | NOVARTIS AG (CH) | 2011-06-28 | — | — | US | disclosed |
| US-20110053892-A1 | Imidazo[4,5-d]Pyridazine Compounds For Treating Viral Infections | LEIVERS MARTIN | 2011-03-03 | — | — | US | disclosed |
| WO-2011026024-A2 | IMIDAZO [4,5-D] PYRIDAZINE COMPOUNDS FOR TREATING VIRAL INFECTIONS | GLAXOSMITHKLINE LLC (US) | 2011-03-03 | — | — | WO | disclosed |
| US-20110052534-A1 | Imidazopyridazine Compounds for Treating Viral Infections | LEIVERS MARTIN | 2011-03-03 | — | — | US | disclosed |
| WO-2011026091-A1 | IMIDAZOPYRIDAZINE COMPOUNDS FOR TREATING VIRAL INFECTIONS | GLAXOSMITHKLINE LLC (US) | 2011-03-03 | — | — | WO | disclosed |
| EP-2164457-A2 | METHOD OF REGULATING HAIR GROWTH | The Procter and Gamble Company (US) | 2010-03-24 | — | — | EP | disclosed |
| US-20100016782-A1 | Method of Regulating Hair Growth | PROCTER & GAMBLE COMPANY, THE | 2010-01-21 | — | — | US | disclosed |
| WO-2008126030-A3 | COMPOSITIONS FOR REGULATION OF HAIR GROWTH | PROCTER & GAMBLE (US) | 2009-03-05 | — | — | WO | disclosed |
| WO-2009010921-A2 | METHOD OF REGULATING HAIR GROWTH | THE PROCTER & GAMBLE COMPANY (US) | 2009-01-22 | — | — | WO | disclosed |
| US-20080269247-A1 | Chemokine Inhibiting Piperazine Derivatives and Their Use to Treat Myocarditis | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-10-30 | — | — | US | disclosed |
| WO-2008126030-A2 | COMPOSITIONS FOR REGULATION OF HAIR GROWTH | THE PROCTER & GAMBLE COMPANY (US) | 2008-10-23 | — | — | WO | disclosed |
| WO-2008126030-A2 | COMPOSITIONS FOR REGULATION OF HAIR GROWTH | THE PROCTER & GAMBLE COMPANY (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080254055-A1 | Compositions for Regulation of Hair Growth | PROCTER & GAMBLE COMPANY, THE | 2008-10-16 | — | — | US | disclosed |
| US-20080254055-A1 | Compositions for Regulation of Hair Growth | PROCTER & GAMBLE COMPANY, THE | 2008-10-16 | — | — | US | disclosed |
| CN-101253449-A | Photosensitive resin composition and photosensitive element | HITACHI CHEMICAL CO LTD (JP) | 2008-08-27 | — | — | CN | disclosed |
| US-20080119471-A1 | Piperazine urea derivatives for the treatment of endometriosis | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-05-22 | — | — | US | disclosed |
| EP-1361849-B1 | CLEANSING COMPOSITION CONTAINING AN AMPHIPHILIC POLYMER | OREAL (FR) | 2008-03-12 | — | — | EP | disclosed |
| US-20070225306-A1 | Compounds and Compositions as Protein Kinase Inhibitors | IRM LLC (BM) | 2007-09-27 | — | — | US | disclosed |
| US-7268140-B2 | Piperazine derivatives and their use as anti-inflammatory agents | SCHERING AG (DE) | 2007-09-11 | — | — | US | disclosed |
| EP-1727526-A2 | PIPERAZINE UREA DERIVATIVES FOR THE TREATMENT OF ENDOMETRIOSIS | Schering Aktiengesellschaft (DE) | 2006-12-06 | — | — | EP | disclosed |
| EP-1713806-A1 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | IRM, LLC (BM) | 2006-10-25 | — | — | EP | disclosed |
| WO-2006066806-A1 | MANUFACTURE OF VITAMIN B6 | DSM IP ASSETS B.V. (NL) | 2006-06-29 | — | — | WO | disclosed |
| US-20060135487-A1 | Piperazine derivatives and their use as anti-inflammatory agents | BAUMAN JOHN G | 2006-06-22 | — | — | US | disclosed |
| EP-1660089-A1 | CHEMOKINE INHIBITING PIPERAZINE DERIVATIVES AND THEIR USE TO TREAT MYOCARDITIS | SCHERING AKTIENGESELLSCHAFT (DE) | 2006-05-31 | — | — | EP | disclosed |
| US-6977258-B2 | Piperazine derivatives and their use as anti-inflammatory agents | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-12-20 | — | — | US | disclosed |
| US-6972290-B2 | Piperazine derivatives and their use as anti-inflammatory agents | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-12-06 | — | — | US | disclosed |
| WO-2005107760-A1 | COMPOUNDS AND COMPOSITIONS AS INDUCERS OF KERATINOCYTE DIFFERENTIATION | IRM LLC (BM) | 2005-11-17 | — | — | WO | disclosed |
| WO-2005079769-A2 | PIPERAZINE DERIVATIVES FOR THE TREATMENT OF ENDOMETRIOSIS | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-09-01 | — | — | WO | disclosed |
| WO-2005080393-A1 | COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | IRM LLC (BM) | 2005-09-01 | — | — | WO | disclosed |
| US-20050192282-A1 | Chemokine inhibiting piperazine derivatives and their use to treat multiple myeloma | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-09-01 | — | — | US | disclosed |
| US-20050130251-A1 | Reagent for determination of hydrogen peroxide | KYOWA MEDEX CO., LTD. (JP) | 2005-06-16 | — | — | US | disclosed |
| EP-1254899-B1 | Piperazine derivatives and their use as anti-inflammatory agents | SCHERING AG (DE) | 2005-05-25 | — | — | EP | disclosed |
| WO-2005018642-A1 | CHEMOKINE INHIBITING PIPERAZINE DERIVATIVES AND THEIR USE TO TREAT MYOCARDITIS | SCHERING AKTIENGESELLSCHAFT (DE) | 2005-03-03 | — | — | WO | disclosed |
| EP-1424554-A1 | REAGENT FOR DETERMINING HYDROGEN PEROXIDE | KYOWA MEDEX CO., LTD. (JP) | 2004-06-02 | — | — | EP | disclosed |
| US-6730672-B2 | PROTEASE INHIBITOR | ZENECA LIMITED (GB) | 2004-05-04 | — | — | US | disclosed |
| EP-1361849-A1 | CLEANSING COMPOSITION CONTAINING AN AMPHIPHILIC POLYMER | L'OREAL (FR) | 2003-11-19 | — | — | EP | disclosed |
| US-20030158205-A1 | Piperazine derivatives and their use as anti-inflammatory agents | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-08-21 | — | — | US | disclosed |
| US-20030139425-A1 | Piperazine derivatives and their use as anti-inflammatory agents | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-07-24 | — | — | US | disclosed |
| US-6573266-B1 | Compounds used for treating multitiple sclerosis and encephalomyelitis | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-06-03 | — | — | US | disclosed |
| WO-2003037279-A1 | USE OF A POLYMER WITH HYDROPHOBIC GROUPS AS A THICKENING OR GELLING AGENT, A COMPOSITION CONTAINING SAME AND THE ASSOCIATED GELATION METHOD | L'OREAL (FR) | 2003-05-08 | — | — | WO | disclosed |
| US-6555537-B2 | Inhibit activity of chemokines, macrophage inflammatory protein-1 (MIP-1 alpha) and RANTES; 1-((4-chlorophenoxy)methyl)-carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine for example | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-04-29 | — | — | US | disclosed |
| US-6541476-B1 | Treating multiple sclerosis or encephalomyelitis in a human | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-04-01 | — | — | US | disclosed |
| US-6534509-B1 | Derivatives are useful as anti-inflammatory agents. This invention is also directed to pharmacetutical compostions for inflammation | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-03-18 | — | — | US | disclosed |
| EP-0988292-B1 | PIPERAZINE DERIVATIVES AND THEIR USE AS ANTI-INFLAMMATORY AGENTS | SCHERING AG (DE) | 2003-02-12 | — | — | EP | disclosed |
| US-20020183313-A1 | 1,4-benzodiazepinones and their uses as CCK antagonists | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-12-05 | — | — | US | disclosed |
| US-20020177598-A1 | Piperazine derivatives and their use as anti-inflammatory agents | SCHERING AKTIENGSCHELLSCHAFT | 2002-11-28 | — | — | US | disclosed |
| EP-1016652-B1 | Process for the preparation of highly pure N-formyl-leucin | ISOCHEM SA (FR) | 2002-11-27 | — | — | EP | disclosed |
| EP-1254899-A2 | Piperazine derivatives and their use as anti-inflammatory agents | Schering Aktiengesellschaft (DE) | 2002-11-06 | — | — | EP | disclosed |
| WO-2002055040-A1 | CLEANSING COMPOSITION CONTAINING AN AMPHIPHILIC POLYMER | L'OREAL (FR) | 2002-07-18 | — | — | WO | disclosed |
| US-20020002163-A1 | 1,4-benzodiazepinones and their uses as CCK antagonists | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-01-03 | — | — | US | disclosed |
| US-6294692-B1 | Process for producing N-formylleucine of high purity | ISOCHEM (FR) | 2001-09-25 | — | — | US | disclosed |
| US-6291452-B1 | CHOLECYSTOKININ ANTAGONISTS. | FUJISAWA PHARMACETICAL CO., LTD. (JP) | 2001-09-18 | — | — | US | disclosed |
| US-6225309-B1 | Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents | ZENECA LIMITED (GB) | 2001-05-01 | — | — | US | disclosed |
| US-6207665-B1 | TO TREAT INFLAMMATORY DISORDERS IN HUMANS | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-03-27 | — | — | US | disclosed |
| EP-1016652-A1 | Process for the preparation of highly pure N-formyl-leucin | ISOCHEM (FR) | 2000-07-05 | — | — | EP | disclosed |
| WO-2000036026-A1 | POWDER PAINT BINDER COMPOSITION | DSM N.V. (NL) | 2000-06-22 | — | — | WO | disclosed |
| US-5965559-A | STRONG INHIBITORY EFFECT AGAINST THE ACTIVATED COAGULATION PROTEASE KNOWN AS FACTOR XA; PREVENTION OF THE CLEAVAGE OF PROTHROMBIN TO THROMBIN; AMINO-SUBSTITUTED PYRIMIDINES AMIDINE GROUP-FREE | ZENECA LIMITED (GB) | 1999-10-12 | — | — | US | disclosed |
| EP-0934282-A1 | 1,4-BENZODIAZEPINONES AND THEIR USES AS CCK ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-08-11 | — | — | EP | disclosed |
| US-5935896-A | ALUMINUM OXIDE-CONTAINING, SILICA-FREE | BASF AKTIENGESELLSCHAFT (DE) | 1999-08-10 | — | — | US | disclosed |
| EP-0783500-B1 | AMINOHETEROCYCLIC DERIVATIVES AS ANTITHROMBOTIC OR ANTICOAGULANT AGENTS | ZENECA LTD (GB) | 1998-07-22 | — | — | EP | disclosed |
| US-5763437-A | Benzodiazepine derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-06-09 | — | — | US | disclosed |
| WO-1998015535-A1 | 1,4-BENZODIAZEPINONES AND THEIR USES AS CCK ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-04-16 | — | — | WO | disclosed |
| EP-0457195-B1 | Peptides having endothelin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same | FUJISAWA PHARMACEUTICAL CO (JP) | 1998-04-15 | — | — | EP | disclosed |
| EP-0804425-A2 | BENZODIAZEPINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-11-05 | — | — | EP | disclosed |
| US-5656604-A | HYPOTENSIVE AGENT; ENDOTHELIN ANTAGONIST | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-08-12 | — | — | US | disclosed |
| US-5556829-A | AMIDES, SULFONAMIDES, PHOSPHOAMIDES, AGRICULTURAL USE | ZAMBON GROUP S.P.A. (IT) | 1996-09-17 | — | — | US | disclosed |
| US-5494666-A | BETA-LACTAMASE INHIBITORS, ANTIBACTERIALS | HOFFMANN-LA ROCHE INC. (US) | 1996-02-27 | — | — | US | disclosed |
| WO-1996004254-A2 | BENZODIAZEPINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-02-15 | — | — | WO | disclosed |
| US-5464617-A | 1H-2,6a-diazacyclobut(cd)indene-6-carboxylic acid derivatives, antibiotics | HOFFMANN-LA ROCHE INC. (US) | 1995-11-07 | — | — | US | disclosed |
| EP-0454067-B1 | Compositions having herbicidal activity containing N-Alkyl-amides as active ingredient | ZAMBON SPA (IT) | 1995-09-27 | — | — | EP | disclosed |
| EP-0627929-A4 | INHIBITORS OF THROMBOSIS. | CORVAS INT INC (US) | 1995-07-12 | — | — | EP | disclosed |
| US-5430022-A | Endothelin antagonists; hypotensive agents; treatment for angina pectoris, brain disorders, asthma, renal failure | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-07-04 | — | — | US | disclosed |
| EP-0647632-A1 | NOVEL BENZODIAZEPINE DERIVATIVE | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1995-04-12 | — | — | EP | disclosed |
| EP-0627929-A1 | INHIBITORS OF THROMBOSIS | CORVAS INTERNATIONAL, INC. (US) | 1994-12-14 | — | — | EP | disclosed |
| WO-1994021673-A1 | ALPHA-KETOAMIDE DERIVATIVES AS INHIBITORS OF THROMBOSIS | CORVAS INTERNATIONAL, INC. (US) | 1994-09-29 | — | — | WO | disclosed |
| US-5336664-A | Compositions having herbicidal activity containing N-alkyl-amides as active ingredient | ZAMBON GROUP S.P.A. (IT) | 1994-08-09 | — | — | US | disclosed |
| US-5334583-A | Topical administrable viricides | CIBA-GEIGY CORP. (US) | 1994-08-02 | — | — | US | disclosed |
| US-5284828-A | Hypotensive agents | FUJISAWA PHARMACEUTICAL CO. LTD. (JP) | 1994-02-08 | — | — | US | disclosed |
| WO-1993015756-A1 | INHIBITORS OF THROMBOSIS | CORVAS INTERNATIONAL, INC. (US) | 1993-08-19 | — | — | WO | disclosed |
| US-5189017-A | Administering salt of muramyl tripeptide derivative | CIBA-GEIGY CORPORATION (US) | 1993-02-23 | — | — | US | disclosed |
| EP-0276124-B1 | PROSTAGLANDIN DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE | Sankyo Company Limited (JP) | 1992-05-20 | — | — | EP | disclosed |
| US-5077427-A | PREPARATION OF ALPHA-FORMYLAMINO NITRILES | BASF AKTIENGESELLSCHAFT (DE) | 1991-12-31 | — | — | US | disclosed |
| US-5077426-A | PREPARATION OF ALPHA-FORMYLAMINO NITRILES | BASF AKTIENGESELLSCHAFT (DE) | 1991-12-31 | — | — | US | disclosed |
| EP-0457195-A2 | Peptides having endothelin antagonist activity, a process for preparation thereof and pharmaceutical compositions comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-11-21 | — | — | EP | disclosed |
| EP-0454067-A1 | Compositions having herbicidal activity containing N-Alkyl-amides as active ingredient | ZAMBON GROUP S.p.A. (IT) | 1991-10-30 | — | — | EP | disclosed |
| US-4981872-A | ANTIULCER | SANKYO COMPANY LIMITED (JP) | 1991-01-01 | — | — | US | disclosed |
| EP-0192976-B1 | COMPOUNDS HAVING ANTIHYPERLIPEMIC ACTIVITY, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BOEHRINGER BIOCHEMIA ROBIN S.p.A. (IT) | 1989-06-14 | — | — | EP | disclosed |
| US-4801580-A | Peptide, process for preparation thereof and use thereof | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1989-01-31 | — | — | US | disclosed |
| EP-0276124-A2 | Prostaglandin derivatives, their preparation and their therapeutic use | Sankyo Company Limited (JP) | 1988-07-27 | — | — | EP | disclosed |
| EP-0102319-B1 | PROPHYLACTIC AND THERAPEUTIC USE OF MURAMYL PEPTIDES AND THEIR ANALOGUES AGAINST VIRAL INFECTIONS | CIBA-GEIGY AG (CH) | 1987-08-19 | — | — | EP | disclosed |
| EP-0231901-A2 | Process for the purification of N-vinyl formamide and poly-N-vinyl formamide prepared therefrom | BASF Aktiengesellschaft (DE) | 1987-08-12 | — | — | EP | disclosed |
| EP-0192976-A1 | Compounds having antihyperlipemic activity, processes for the preparation thereof and pharmaceutical compositions containing them | BOEHRINGER BIOCHEMIA ROBIN S.p.A. (IT) | 1986-09-03 | — | — | EP | disclosed |
| US-4423038-A | Phosphoryl compounds, pharmaceutical preparations containing such compounds, and their use | CIBA-GEIGY CORPORATION (US) | 1983-12-27 | — | — | US | disclosed |
| EP-0056992-A1 | Phosphorylated derivatives, pharmaceutical compositions containing such derivatives, and their use | CIBA-GEIGY AG (CH) | 1982-08-04 | — | — | EP | disclosed |
| US-4322271-A | ETHERIFICATION OF AN N-ETHYL AMIDE BY ANODIZING WITH AN ALCOHOL; ALKYLATION; DEETHERIFICATION | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-03-30 | — | — | US | disclosed |
| EP-0012194-B1 | PROCESS FOR THE PREPARATION OF N-CARBOXYALKYL-1-AMINOALKANE DIPHOSPHONIC ACIDS AND CARBOXYALKYLAMINO-PHENYL-METHANE DIPHOSPHONIC ACIDS | Benckiser-Knapsack GmbH (DE) | 1982-02-03 | — | — | EP | disclosed |
| EP-0012194-A1 | Process for the preparation of N-carboxyalkyl-1-aminoalkane diphosphonic acids and carboxyalkylamino-phenyl-methane diphosphonic acids | Benckiser-Knapsack GmbH (DE) | 1980-06-25 | — | — | EP | disclosed |
| US-3949079-A | PLEUROMUTILIN; BACTERICIDES IN ANIMAL FEEDS | BIOCHEMIE GES.M.B.H. (OE) | 1976-04-06 | — | — | US | disclosed |
| US-3949079-A | PLEUROMUTILIN; BACTERICIDES IN ANIMAL FEEDS | BIOCHEMIE GES.M.B.H. (OE) | 1976-04-06 | — | — | US | disclosed |